Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.93 $0.08 (7.92%) RKDA stock closing price Jan 20, 2017 (Closing)

RKDA stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Arcadia Biosciences stock price. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the RKDA stock is bound to reflect the impact of the QoQ growth of $0.36M. The Arcadia Biosciences profit and loss statement for 2016-Q3 shows a profit of $-4.18M. Profits have grown from $-4.55M QoQ. Apart from this an investor should also check Arcadia Biosciences assets and Arcadia Biosciences free cash flow. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Arcadia Biosciences Net Sales or Revenues
1.08M0.72M0.85M1.35M1.82M1.43M0.82M2.8M1.5M1.31M
Cost Of Goods Sold (COGS)0.06M0.03M0.14M0.68M0.06M0.1M0.05M0.07M1.79M0.04M
Arcadia Biosciences Gross Profit
1.01M0.68M0.7M0.69M1.76M1.32M0.75M2.74M-0.29M1.25M
Research & Development Expense2.25M2.21M2.2M1.88M3.17M2.08M1.83M2.08M3.68M2.27M
Selling General & Admin Expense2.68M2.75M3.43M2.89M2.81M2.78M2.63M2.3M1.96M3.98M
Income Before Depreciation Depletion Amortization-3.92M-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M-5.94M-4.99M
Depreciation Depletion Amortization----------
Non Operating Income0.09M0.07M0.07M0.67M0.28M0.73M-1.39M0.02M-0.81M0.22M
Interest Expense0.33M0.32M0.32M0.66M0.76M0.77M0.46M0.36M0.26M0.39M
Arcadia Biosciences Pretax Income
-4.16M-4.54M-5.18M-4.07M-4.71M-3.58M-5.57M-1.97M-7.02M-5.17M
Provision for Income Taxes0.01M0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M0.04M0.09M
Minority Interest----------
Investment Gains Losses--------0.01M--0.53M
Other Income----------
Income Before Extraordinaries & Disc Operations-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Average Shares used to compute Diluted EPS44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M
Average Shares used to compute Basic EPS44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M
Income Before Nonrecurring Items-4.18M-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Income from Nonrecurring Items----0.23M------
Arcadia Biosciences Earnings Per Share Basic Net
-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19-3.08
Arcadia Biosciences Earnings Per Share Diluted Net
-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19-3.08
EPS Diluted Before Nonrecurring Items-0.09-0.10-0.12-0.08-0.11-0.19-3.71-1.76-4.19-3.08
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Arcadia Biosciences stock analysis involves checking at least a few of the important things like:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that RKDA stock has a topline or revenue of $1.08M for 2016-Q3 as per this Arcadia Biosciences revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-4.18M for Arcadia Biosciences for 2016-Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called statement of revenue and expense. The financials along with Arcadia Biosciences historical stock prices provides a lot of details about the firm. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
10.3160
Operating margin
-363
Net profit margin
-387
Dividend yield
0%